BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23770226)

  • 1. Mathematical modeling of drug release from nanostructured porous Si: combining carrier erosion and hindered drug diffusion for predicting release kinetics.
    Tzur-Balter A; Young JM; Bonanno-Young LM; Segal E
    Acta Biomater; 2013 Sep; 9(9):8346-53. PubMed ID: 23770226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride.
    Tzur-Balter A; Gilert A; Massad-Ivanir N; Segal E
    Acta Biomater; 2013 Apr; 9(4):6208-17. PubMed ID: 23274152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid.
    Anglin EJ; Schwartz MP; Ng VP; Perelman LA; Sailor MJ
    Langmuir; 2004 Dec; 20(25):11264-9. PubMed ID: 15568884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Be a Bimetal Oxide ZnO-MgO Nanoparticles Anticancer Drug Carrier and Deliver? Doxorubicin Adsorption/Release Study.
    Kumar R; Gokulakrishnan N; Kumar R; Krishna VM; Saravanan A; Supriya S; Somanathan T
    J Nanosci Nanotechnol; 2015 Feb; 15(2):1543-53. PubMed ID: 26353689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular release from patterned nanoporous gold thin films.
    Kurtulus O; Daggumati P; Seker E
    Nanoscale; 2014 Jun; 6(12):7062-71. PubMed ID: 24842586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.
    Limnell T; Riikonen J; Salonen J; Kaukonen AM; Laitinen L; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Oct; 343(1-2):141-7. PubMed ID: 17600644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Surface Chemistry on the Release of an Antibacterial Drug from Nanostructured Porous Silicon.
    Wang M; Hartman PS; Loni A; Canham LT; Bodiford N; Coffer JL
    Langmuir; 2015 Jun; 31(22):6179-85. PubMed ID: 25970551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications.
    Jarvis KL; Barnes TJ; Prestidge CA
    Adv Colloid Interface Sci; 2012 Jul; 175():25-38. PubMed ID: 22521238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity.
    Luo Z; Cai K; Hu Y; Zhang B; Xu D
    Adv Healthc Mater; 2012 May; 1(3):321-5. PubMed ID: 23184747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion dynamics of small molecules from mesoporous silicon films by real-time optical interferometry.
    Mares JW; Weiss SM
    Appl Opt; 2011 Sep; 50(27):5329-37. PubMed ID: 21947054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug delivery.
    Liu D; Zhang H; Herranz-Blanco B; Mäkilä E; Lehto VP; Salonen J; Hirvonen J; Santos HA
    Small; 2014 May; 10(10):2029-38. PubMed ID: 24616278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained antibacterial activity from triclosan-loaded nanostructured mesoporous silicon.
    Wang M; Coffer JL; Dorraj K; Hartman PS; Loni A; Canham LT
    Mol Pharm; 2010 Dec; 7(6):2232-9. PubMed ID: 20973523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycaprolactone thin-film drug delivery systems: Empirical and predictive models for device design.
    Schlesinger E; Ciaccio N; Desai TA
    Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():232-9. PubMed ID: 26354259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselectively controlled release of chiral drug (metoprolol) using chiral mesoporous silica materials.
    Guo Z; Du Y; Liu X; Ng SC; Chen Y; Yang Y
    Nanotechnology; 2010 Apr; 21(16):165103. PubMed ID: 20351409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silicon in drug delivery applications.
    Salonen J; Kaukonen AM; Hirvonen J; Lehto VP
    J Pharm Sci; 2008 Feb; 97(2):632-53. PubMed ID: 17546667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronically-responsive delivery from a calcified mesoporous silicon structure.
    Batra I; Coffer JL; Canham LT
    Biomed Microdevices; 2006 Jun; 8(2):93-7. PubMed ID: 16688568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective functionalization of the internal and the external surfaces of mesoporous silicon by liquid masking.
    Wu CC; Sailor MJ
    ACS Nano; 2013 Apr; 7(4):3158-67. PubMed ID: 23451853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in porous silicon technology for drug delivery.
    Barnes TJ; Jarvis KL; Prestidge CA
    Ther Deliv; 2013 Jul; 4(7):811-23. PubMed ID: 23883125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling antibiotic release from mesoporous silica nano drug carriers via self-assembled polyelectrolyte coating.
    Tamanna T; Bulitta JB; Yu A
    J Mater Sci Mater Med; 2015 Feb; 26(2):117. PubMed ID: 25665846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.